RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medartis Holding Stock

Medartis Holding P/S 2025

Medartis Holding P/S

3.28

Ticker

MED.SW

ISIN

CH0386200239

WKN

A2JGBF

As of Feb 21, 2025, Medartis Holding's P/S ratio stood at 3.28, a 12.33% change from the 2.92 P/S ratio recorded in the previous year.

The Medartis Holding P/S history

Medartis Holding Aktienanalyse

What does Medartis Holding do?

Medartis Holding AG is a Swiss company specializing in the development and manufacturing of implants and instruments for traumatology, hand and foot surgery, and upper and lower limb reconstruction. The company was founded in 1997 by a group of doctors who decided to develop innovative products that meet the needs of patients and surgeons. The business model of Medartis is based on the sale of implants and instruments developed in close collaboration with leading surgeons. The company places particular emphasis on the use of high-quality materials and high processing quality. With this philosophy, the company has quickly gained an excellent reputation, which is also reflected in the increasing demand for its products. The company is divided into various specialized areas, each offering specialized products and solutions. One of Medartis' main areas is traumatology, which specializes in the treatment of injuries and fractures. In this area, the company offers a variety of implants and instruments tailored to the needs of surgeons and patients. Products such as plates, screws, and nails ensure that bone fractures can be stabilized and healed. Another important area of Medartis is hand surgery. Here, the company has a wide portfolio of implants and instruments tailored to the specific requirements of hand operations. One of the well-known solutions is the finger fixator, a small but very effective device used in the treatment of finger fractures. In the field of foot surgery, Medartis also offers a variety of solutions. From implants for stabilizing ankle and foot joints to instruments for correcting deformities, the company has a broad range of products. Particularly noteworthy are the implants and instruments used in the treatment of hallux valgus, commonly known as bunions. In addition to these traditional areas, Medartis also has products and solutions in its portfolio specialized in the reconstruction of the upper and lower limbs. These include implants and instruments for the treatment of spinal injuries as well as solutions for the reconstruction of knee or hip joints. Overall, in recent years, Medartis has established itself as one of the leading providers of implants and instruments in the field of traumatology, hand and foot surgery, and upper and lower limb reconstruction. With its innovative product range and high-quality standards, the company has gained an excellent reputation that will continue to drive increasing demand in the future. Medartis Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Medartis Holding's P/S Ratio

Medartis Holding's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Medartis Holding's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Medartis Holding's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Medartis Holding’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Medartis Holding stock

What is the price-to-earnings ratio of Medartis Holding?

The price-earnings ratio of Medartis Holding is currently 3.28.

How has the price-earnings ratio of Medartis Holding changed compared to last year?

The price-to-earnings ratio of Medartis Holding has increased by 12.33% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Medartis Holding high compared to other companies?

Yes, the price-to-earnings ratio of Medartis Holding is high compared to other companies.

How does an increase in the price-earnings ratio of Medartis Holding affect the company?

An increase in the price-earnings ratio of Medartis Holding would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Medartis Holding affect the company?

A decrease in the price-earnings ratio of Medartis Holding would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Medartis Holding?

Some factors that influence the price-earnings ratio of Medartis Holding are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Medartis Holding pay?

Over the past 12 months, Medartis Holding paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medartis Holding is expected to pay a dividend of 0 CHF.

What is the dividend yield of Medartis Holding?

The current dividend yield of Medartis Holding is .

When does Medartis Holding pay dividends?

Medartis Holding pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medartis Holding?

Medartis Holding paid dividends every year for the past 0 years.

What is the dividend of Medartis Holding?

For the upcoming 12 months, dividends amounting to 0 CHF are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medartis Holding located?

Medartis Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medartis Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medartis Holding from 2/21/2025 amounting to 0 CHF, you needed to have the stock in your portfolio before the ex-date on 2/21/2025.

When did Medartis Holding pay the last dividend?

The last dividend was paid out on 2/21/2025.

What was the dividend of Medartis Holding in the year 2024?

In the year 2024, Medartis Holding distributed 0 CHF as dividends.

In which currency does Medartis Holding pay out the dividend?

The dividends of Medartis Holding are distributed in CHF.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medartis Holding

Our stock analysis for Medartis Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medartis Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.